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In the past, it was thought that hearing loss patients with residual low-frequency hearing would not be good candidates for cochlear
implantation since insertion was expected to induce inner ear trauma. Recent advances in electrode design and surgical techniques
havemade the preservation of residual low-frequency hearing achievable and desirable.The importance of preserving residual low-
frequency hearing cannot be underestimated in light of the added benefit of hearing in noisy atmospheres and in music quality.
The concept of electrical and acoustic stimulation involves electrically stimulating the nonfunctional, high-frequency region of
the cochlea with a cochlear implant and applying a hearing aid in the low-frequency range. The principle of preserving low-
frequency hearing by a “soft surgery” cochlear implantation could also be useful to the population of children who might profit
from regenerative hair cell therapy in the future. Main aspects of low-frequency hearing preservation surgery are discussed in this
review: its brief history, electrode design, principles and advantages of electric-acoustic stimulation, surgical technique, and further
implications of this new treatment possibility for hearing impaired patients.
1. Introduction
In the past three decades, cochlear implantation has evolved
from an experimental procedure to represent the standard
of care for deaf patients. Advances in processing strategies,
implant design, and patient selection criteria have signif-
icantly improved implant users’ performance. Nowadays,
the current frontiers in implantation involve strategies to
preserve residual acoustic hearing and the development of
algorithms to combine electrical and acoustic hearing. More-
over, it is important to keep inmind that, by preserving apical
organ of Corti structures, it is possible to take advantage of
new technologies that may lead to regeneration of the inner
ear in the future [1].
Cochlear implantation with a standard-length electrode
has been a reality in treating patients who have profound
deafness. However, the loss of residual acoustic hearing
following cochlear implantation is an important clinical con-
sideration when determining the most appropriate options
for patients with severe hearing losses [2]. There are some
patients with substantial low-frequency acoustic hearing up
to 1500Hz and severe to profound high-frequency hearing
loss that do poorly with bilateral amplification who have
not been considered as candidates for implantation using
standard criteria [3].
High frequencies report information about vocal vibra-
tion (like the ability to distinguish between “s” and “z”),
whereas lower frequencies apprise information regarding the
vocal formants and spectral patterns (such as the difference
between “b” and “g”) [4]. Patients with high-frequency losses
are able to distinguish loudness and speech pattern (due
to their low-frequency acoustic hearing), but they cannot
interpret spectral patternswell (which erodes their capacity to
distinguish between the different consonant sounds and thus
their word discrimination scores) [5].
The loss of low-frequency hearing during cochlear
implantation is the result of the technique used to create the
cochleostomy and its size combined with the characteristics
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of the electrode design (diameter, stiffness, and length) since
it may induce substantial damage to the basilar membrane
and cochlear hair cells as it advances into the scala tympani
[1, 2].
2. Electric-Acoustic Stimulation (EAS)
2.1. Shortened Electrodes. It is known that cochlear implanta-
tion with a standard-length electrode and standard surgical
technique in patients with some residual hearing results
in complete loss of the remaining acoustic hearing [6, 7].
Nevertheless, since Hodges et al. [8] presented a series of
patients who had undergone implantation and had preserved
residual hearing, many studies have demonstrated the ability
to retain residual low-frequency hearing in standard-length
electrode implantation [9, 10].
The idea of acoustic plus electric hearingmeans a cochlear
implant aided by an ipsilateral hearing aid, to benefit from
the residual low-frequency hearing of an individual.This idea
of electric-acoustic stimulation (EAS) first emerged from the
work of two independent groups, one from Iowa, USA, and
the other from Frankfurt, Germany. In 1995, the University
of Iowa Cochlear Implant research team along with the
Cochlear Corporation (Lane Cove, Australia) developed a
shortened electrode array called theHybrid S. It was designed
to be inserted only into the lower basal turn of the cochlea and
thus stimulate the missing areas of high frequency for those
specific patients with preserved low-frequency thresholds
[2]. The Hybrid S electrode has a smaller diameter than
the standard electrode (0.2mm × 0.4mm) and initially, it
was 6mm in length and it contained 6 electrodes. Because
some patients reported a very high-pitched sound [11], it was
then lengthened to 10mm, still with 6 electrodes. The ideal
insertion depth is at approximately 195∘ of the basal turn of
the cochlea [12].
In 2003, Gantz and Turner [11] reported the first 6
patients implanted with the Hybrid S electrode, three of
which received the 6mm electrode and the other three
received the 10mm electrode. Patients who received the
6mm electrode improved their consonant recognition scores
by 10%, whereas those who received the 10mm electrode
improved by 40%. Also, patients who received the 10mm
electrode did better in the combinedmode (cochlear implant
+ bilateral hearing aids) than those who received the 6mm
electrode [13]. A larger multicenter phase 1 FDA trial was
conducted for the Hybrid S 10mm electrode with 87 patients
from 13 centers, and preliminary data was published in 2009
[14]. Two patients lost all residual hearing within 1 month
of implantation (initial hearing preservation rate (IHPR) of
98%). Between 3 and 24 months after activation, 6 more
patients lost residual hearing (IHPR of 91%). Over time,
30% of the patients had a low-frequency threshold drop of
more than 30 decibels (dB). A duration of deafness of over
40 years and low preoperative consonant-nucleus-consonant
(CNC) word scores were found to have a negative impact on
functional outcomes [14].
Another short electrode named Hybrid L24 has been
developed in conjunction with the Cochlear Corporation. It
contains 22 electrodes that are 16mm long and its optimal
insertion is 250∘ of the basal turn of the cochlea. It would
still preserve the residual hearing from the apical portions
of the cochlea and if the low-frequency hearing is lost, it
can be used as a traditional electric device since it has 22
electrodes, similar to a standard one. The FDA trial for the
Hybrid L has not been published yet, but the preliminary
results from the European clinical trial [15] demonstrated the
ability to preserve residual hearing. Thirty-two patients were
enrolled, 24 of whom were hybrid candidates and 8 long-
electrode candidates. In 96% of the subjects, hearing was
preservedwithin 30 dB of preoperative thresholds and in 68%
within 15 dB. These results were stable over time and there
was a significant improvement in word scores between the 6-
month and 12-monthmarks, demonstrating, as in the Hybrid
S trial, that there is a learning period for patients with short
electrodes [16].
The Med-El Corporation has also developed a shortened
electrode called M, which is 22mm long with an ideal
insertion of 360∘ from the basal turn of the cochlea. It has a
very flexible tip and a significantly reduced diameter in the
distal portion. This FlexEAS electrode can be used for both
round window insertion and cochleostomy techniques [17].
Much of the data regarding FlexEAS involves mixed cohorts
of patients. Gstoettner et al. in 2008 [18] reported a series of
18 patients implanted with the M electrode. Twelve of the 18
(68%) had low-frequency hearing preservation that could be
usefully amplified. Three of the patients had some residual
low-frequency hearing but did not find amplification useful.
Three of the 18 (16%) lost all residual hearing. Interestingly,
the loss of the residual hearing was not immediate, but
delayed by 3 to 6 months after hybrid activation.
2.2. Standard-Length Electrodes. An alternative strategy for
preserving the low-frequency hearing was developed with
standard-length electrodes, but limiting the depth of inser-
tion. Kiefer et al. [7] implanted 14 patients with the Med-
El Combi40+ electrode, limiting the length of insertion to
less than 24mm (full insertion is 31.5mm) and using a “soft
insertion” technique. In 12 out of the 14 patients (85%), useful
low-frequency hearing (less than 20 dB drop in thresholds)
was maintained, with 2 patients losing all residual hearing.
Using a standard-length electrode and modified surgical
techniques, other authors have reported rates from 67%
to 89% of hearing preserved within 20 dB of preoperative
thresholds [7, 19–22]. Nevertheless, not all of these patients
maintain the ability to discriminate. Balkany et al. reported
that although patients experienced only a 15 dB drop in the
low frequencies, the average acoustic CNC postoperative
word score was 0% [9].
2.3. Discussion. There is controversy in the literature about
the preferred electrode length. There is a higher rate of
reduced thresholds and anacusis with the long electrodes.
Some authors defend this reason for its use, so if residual
hearing is lost, the patient can have the full-length electrode
to benefit from its electric-only listening mode, which would
not happen with a short electrode. Since the short electrode
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is 10mm long, it accesses only the 2800 to 4700Hz range
according to the Greenwood frequency placement map of
the basilar membrane. Even though this was thought to be
a tonotopic mismatch, which could impair discrimination,
Hybrid S electrode users in electric-only mode showed
similar performance as long-electrode users on consonant
recognition tasks [23]. Improved performance with the
Hybrid S electrode appears to require a longer time (over 12
months) than the long-electrode (usually 6 to 12 months to
adapt to electric hearing) [16, 23].
One argument in favor of long electrode used to be
the likelihood of progressive low-frequency hearing loss.
However, Yao et al. [24] demonstrated a loss of only 1.05 dB
in low-frequency hearing (up to 2000Hz) per year in Hybrid
S users, regardless of their age. It seems that low-frequency
hearing is relatively stable over time. If it can be preserved at
the time of implantation, it is likely that the patient will have
minimal further hearing loss in the long term [24].
Another concern regarding Hybrid or EAS studies is the
progression of hearing loss after activation. At the time of
implantation, very few patients lose all their residual low-
frequency hearing. In the phase 1 Hybrid S10 trial [14], 2%
of the patients lost their residual low-frequency hearing, and
within 3 months of activation, 10% of the initial number of
patients had a 30 dB drop from their preoperative thresholds
up to 500Hz. The cause of this loss is still unknown; some
hypotheses suggest an immune reaction to the electrode,
loss of afferent spiral ganglion neuron synapses at the hair
cell related to the combination of acoustic amplification and
electrical stimulation, or even an initial injury from noise-
induced hearing loss [25].
Steroids have been shown to reduce noise-induced
cochlear damage and hearing loss and to increase recovery
after noise trauma. However, their efficacy has been contro-
versially discussed due to a lack of adequate clinical trials
[1]. Also, there is controversy regarding drug application
methods, be it systemic or local, either via diffusion from
the middle ear space through the round window membrane
or by direct instillation into the perilymphatic space. A
single-shot intracochlear glucocorticoid application appears
to be a promising method for reducing progressive hearing
loss caused by electrode insertion trauma due its long-term
effects, such as reduction of inflammatory processes [1].
Further in vitro studies with otoprotective drugs believed
to bring new perspectives on an improved rate of hearing
preservation are promising [1, 26, 27].
3. Indication Guidelines for EAS
In the initial studies, the indication was closer to standard
cochlear implantation for thresholds above 65 dB in the low
frequencies between 125 and 500Hz [28]. After encourag-
ing results from these studies, the criteria were gradually
expanded to normal low-frequency hearing in the frequen-
cies up to 1500Hz (partial deafness cochlear implantation)
[29].
Actual guidelines determine that pure tone audiometry
scores for both ears have to be greater than 60 dB between
125 and 500Hz and below 70 dB at 1500. In addition,
monosyllables tested at a 10 dB signal-to-noise ratio (SNR)
should not exceed a score of 40% in the best aided condition
[1]. Further, these patients must have substantial CNC word
scores in the best aided condition, with between 10% and 60%
correct in the worse hearing ear and up to 80% correct in the
best hearing ear.
4. Surgical Technique for
Hearing Preservation
Wright and Roland in 2005 [30] first described a “soft
surgery” technique, which was later modified by other
authors [7, 12, 13]. When developing new strategies, the most
import factors that contribute to possible cochlear damage
during or after the surgery must be kept in mind [1]:
(i) mechanical damage during electrode insertion (frac-
tures of the osseous spiral lamina, disruption of
the basilar membrane, tearing of the lateral spiral
ligament, and leakage of traumatized blood vessels),
(ii) shock waves in the perilymph fluid due to implanta-
tion,
(iii) acoustic trauma due to drilling,
(iv) loss of perilymph and disruption of inner ear fluid
homeostasis,
(v) potential bacterial infection,
(vi) secondary intracochlear fibrous tissue formation.
The technique used at the University of Iowa for implan-
tation of the cochlear Hybrid S and L devices is described in
this review.
A standard mastoidectomy is performed through a post-
auricular incision. A portion of the superior margin of the
mastoid cortex is left in place and a suture is passed through
the cortex to anchor the electrode before placing it in the
cochlea. The objective of this suture is to reduce the spring
of the electrode and to prevent movement of the electrode
during placement in the scala tympani (ST). A bonny well
for the internal processor is also created in the same manner
used for a standard cochlear receiver/stimulator. A ridge of
bone between the mastoid cavity and the well is left so the
implant does not later slide. A subperiosteal pocket is created
deeply to the temporalis muscle and pericranium. The facial
recess is openedwidely, and the roundwindowniche is totally
exposed by removing the bone overlying and anterior to the
facial nerve. With a 1mm diamond burr, the bony overhang
of the roundwindowniche is drilled away to expose the entire
round window membrane.
Before creating the cochleostomy, the surgical field must
be extensively irrigated and meticulous hemostasis must be
done in order to prevent bone chips and blood debris from
entering into the cochlea upon opening.The cochleostomy is
created in the inferior-posterior quadrant of a box created by
drawing a line at the superior margin of the round window
and a perpendicular line at the inferior margin of the round
window [2]. Entering into the scala tympani in this specific
4 International Journal of Otolaryngology
location prevents damage to the basilarmembrane and avoids
injury to inner ear structures by facilitating insertion of
the electrodes in the correct trajectory [3]. Although in
the United States a cochleostomy is the preferred strategy
for placing the electrode, many European surgeons usually
prefer the round window approach [3]. The round window
technique may result in a conductive hearing loss [15] and it
predisposes to fracturing the osseous spiral lamina, according
to some studies [30, 31]. A recent systematic review [32],
however, did not show any benefit of one surgical approach
over the other regarding the preservation of residual hearing.
The electrode and processor must be seated in position
before opening the endosteum of the cochleostomy. Two
holes are drilled into the tegmen tympani, which allow a 2-
0 or 4-0 nylon suture to be passed through the bone in order
to secure the Hybrid S and L electrode array (not the ground
electrode). Once the processor and electrode are seated and
secured, a temporalis fascia “washer” with a 1.5mm × 1.5mm
diameter is harvested and flattened in a fascial tissue press. It
is then punctured with a straight needle and the electrode is
inserted through the fascia up to the Dacron collar in order
to seal the scala tympani at the cochleostomy. Opening the
endosteum into the scala tympani with a 0.2mm footplate
hookmust be the final act of the procedure to reduce the time
the cochlea is open. The electrode is advanced slowly into
the scala tympani (over 1 to 2 minutes) in order to minimize
insertional trauma and to allow perilymph displacement.
There are some intraoperative tests described in order to
further improve the safety of hearing preservation surgery,
such as the measure of cochlear microphonics [1] and audi-
tory brainstem response (ABR) during electrode insertion
[3]. Likewise, Oghalai et al. [33] used auditory steady-state
response audiometry to access hearing thresholds during
regular cochlear implantation and draw the surgeon’s atten-
tion to the critical moments of the insertion procedure. The
surgeon must pause during the insertion to allow data for
these tests to be collected.
The middle ear is not packed with muscle or fascia.
The periosteum should then be closed completely over the
receiver/stimulator and the electrode. Soft tissues are then
closed in the standard way.
Helbig et al. [34] recently reported a series of 3 patients
in whom revision surgery for cochlear implantation was
required. Reimplantation was possible in these patients who
had previously undergone EAS surgery with the preservation
of low-frequency hearing and without losing the residual
hearing function. Also, a reduced insertion depth at the
initial surgery could be followed by deeper insertion into the
cochlea without any deterioration of residual hearing [34].
5. Benefits of Acoustic and Electric Processing
Current literature has already reported several discrete
advantages to both modalities, but the full benefits of an EAS
of the ipsilateral cochlea are still under investigation.
5.1. Speech Perception with EAS. Patients with preserved low-
frequency hearing show significant improvements in their
discrimination scores. Hybrid S electrode users continue to
improve on CNC scores over 1 to 2 years after activation.
In the Hybrid S trial [14], 48% of the patients showed
improvement in both SRT and CNC scores. Improvement
on CNC testing ranged from 10% to 70% over preoperative
scores for 73% of the patients with long-term followups [14].
For those implanted with the Hybrid L24, word recognition
scores improved by 21% on average; one single patient had
improvement from 5% to 95% on the Freiburg monosyllabic
word test (FMT) [15].
Exceptional improvement in speech understanding is
possible for patients in the combinedmodewith all electrodes
activated: some patients score more than 90% on the CNC
monosyllabic word test. FlexEAS users had preoperatively
open-set sentence recognition of 24% and after 12 months
of use, scores averaged 71%. Monosyllable recognition also
improved from 16% to 44% on average.
Improvements in discrimination tasks have also been
observed in long-electrode users with preserved acoustic
hearing. Patients who received theMed-El Combi40+with 19
to 24mm of insertion scored 75% on monosyllabic tests after
1 year, an important improvement from the 9% preoperative
scores.
5.2. Hearing in Noisy Backgrounds. Distinguishing the cor-
rect words in a background of competing talkers is a chal-
lenging test for traditional cochlear implant users. Normal-
hearing listeners have a signal-to-noise ratio (SNR) of −30 dB
and −15 dB for competing talkers [35]. The average SNR of
a long-electrode user is +3 dB for unmodulated background
noise and +8 for multitalker babble (MTB), which means the
talker has to speak 3 dB louder than the competing noise or
8 dB louder than MTB.
Hybrid S users do better than traditional cochlear implant
patients, but not as well as normal-hearing listeners in noisy
backgrounds. In a subgroup of 27 Hybrid S patients with at
least 12months of activation, SNRs ranged from−12 to +17 dB
(average −9 dB) [14]. Patients who had a drop greater than
30 dB in their low-frequency hearing experienced a worse
SNR.
Hybrid L electrode patients also improved their SNR
preoperatively from 12.1 dB to 2.1 dB postoperatively [15].
Those with the FlexEAS electrode changed their preoperative
open-set sentence scores with a SNR of +10 dB from 14% to
60% after 1 year of activation [18].
Long-electrode users with preserved hearing in low
frequencies also benefit when listening in noise. Med-El
Combi40+ users with a low-frequency threshold of <80 dB
scored better than patients with a cochlear implant and no
residual hearing with a SNR of +5 dB [19]. Gstoettner et
al. showed an increase in understanding scores from 13.1%
preoperatively to 75% in the electric-acoustic stimulation
condition [22].
5.3. EAS and Music Perception. It is known that traditional
cochlear implant users have difficulties identifying and enjoy-
ingmusic because of the extremely complex encoded spectral
information. They can usually distinguish lyrics to a certain
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degree but have significant trouble with pitch, timbre, and
melody recognition [35, 36].
Music appreciation has been a part of the research
protocol for the Hybrid S/L trials. Patients with preserved
acoustic hearing have a distinct advantage over traditional
cochlear implant users regarding pitch, lyrics, melody, and
timbre of the instruments.WhenHybrid users were provided
with excerpts of easily recognizable American songs, they
were able to correctly identify the songs 65%–100% of the
time, similar to normal-hearing listeners. In tasks regarding
pitch recognition and melody without lyrics, the Hybrid
users still scored better than the traditional cochlear implant
patients, but not as well as normal-hearing listeners did [36,
37].
Brockmeier et al. [38] studied music testing in EAS
patients with long-electrode insertion (Med-El Combi40+).
Thirteen EAS patients were compared with long-electrode
users with no residual hearing and normal-hearing listeners.
Subjects were matched by age and musical experience. EAS
patients did as well as normal-hearing listeners on pitch
discrimination and better than traditional cochlear implant
users. However, EAS patients’ scores in melody discrimi-
nation, instrument detection, and instrument identification
were not significantly different from those of traditional
cochlear implant users.
6. Future of Hybrid-Type
Cochlear Implantation
Apical cochlear preservation may become a significant issue
in the future. It is possible that treatments will emerge that
require na¨ıve cochlear tissue (i.e., hair cell generation or tissue
transfer). This concern is relevant for families weighing the
risks and benefits of bilateral cochlear implantation for deaf
children. The Iowa CI research team has recently reported
a series of 9 children with bilateral implants: one ear with
a standard long electrode and the other with Hybrid S12
research electrode [39]. The children were only 12 to 24
months old at the time of implantation and they scored an
average of 80 in Preschool Language Scale-3 (PLS-3), whereas
the average score in the same test for children with bilateral
standard electrodes is 83. A long-term followup is necessary
to determine whether the trends of the preliminary data are
long-lasting; a larger-scale study is being carried out.
7. Conclusion
Although hearing preservation in cochlear implantation is
technically challenging, the importance of preserving resid-
ual low-frequency hearing cannot be underestimated in light
of the added benefit of hearing in noisy atmospheres and
music quality for EAS users. Electrode designs and proces-
sor technology are constantly being improved. Nowadays,
patients undergoing hearing preservation surgery can expect
a long-term low-frequency hearing preservation rate of 50–
70%. Although surgeons have largely modified the initially
described “soft surgery” technique over the years, there is not
a unique protocol to be followed.
Few would have imagined the progress that has been
made in the past 30 years regarding aiding deafened patients,
and the future promises to be equally exciting. The potential
EAS advantages highlight the value of the endeavors to
preserve low-frequency hearing in the implanted ear and to
continue amplification where appropriate. Further research
is also needed to maximize outcomes for recipients with
different degrees of hearing losswhouse devices that combine
electric and acoustic stimulation.
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